These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9767459)

  • 41. Mapping of V beta 11+ helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis.
    Yanagisawa S; Koike M; Kariyone A; Nagai S; Takatsu K
    Int Immunol; 1997 Feb; 9(2):227-37. PubMed ID: 9040005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.
    You Q; Jiang C; Wu Y; Yu X; Chen Y; Zhang X; Wei W; Wang Y; Tang Z; Jiang D; Wu Y; Wang C; Meng X; Zhao X; Kong W
    Scand J Immunol; 2012 Jan; 75(1):77-84. PubMed ID: 21916923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
    Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
    Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis.
    Jo EK; Kim HJ; Lim JH; Min D; Song Y; Song CH; Paik TH; Suhr JW; Park JK
    Scand J Immunol; 2000 Feb; 51(2):209-17. PubMed ID: 10652166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic cell presentation of PPD and 19 kDa protein of Mycobacterium tuberculosis and emergent T helper cell phenotype.
    Baird MA; Hart DN; Abernethy N; Watson JD
    Immunol Cell Biol; 1995 Dec; 73(6):537-43. PubMed ID: 8713475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.
    van Pinxteren LA; Ravn P; Agger EM; Pollock J; Andersen P
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):155-60. PubMed ID: 10702486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens.
    Orme IM; Miller ES; Roberts AD; Furney SK; Griffin JP; Dobos KM; Chi D; Rivoire B; Brennan PJ
    J Immunol; 1992 Jan; 148(1):189-96. PubMed ID: 1727865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.
    Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W
    Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of Brucella abortus lipopolysaccharide as an adjuvant for tuberculin PPD.
    Jamalan M; Ardestani SK; Zeinali M; Mosaveri N; Mohammad Taheri M
    Biologicals; 2011 Jan; 39(1):23-8. PubMed ID: 20965746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
    Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Active tuberculosis is characterized by an antigen specific and strictly localized expansion of effector T cells at the site of infection.
    Nemeth J; Rumetshofer R; Winkler HM; Burghuber OC; Müller C; Winkler S
    Eur J Immunol; 2012 Nov; 42(11):2844-50. PubMed ID: 22821397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.
    Derrick SC; Yabe IM; Yang A; Morris SL
    Vaccine; 2011 Apr; 29(16):2902-9. PubMed ID: 21338678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients.
    Sester M; Sester U; Clauer P; Heine G; Mack U; Moll T; Sybrecht GW; Lalvani A; Köhler H
    Kidney Int; 2004 May; 65(5):1826-34. PubMed ID: 15086923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
    Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
    Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice.
    Ancelet L; Rich FJ; Delahunt B; Kirman JR
    Tuberculosis (Edinb); 2012 Sep; 92(5):422-33. PubMed ID: 22738879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
    Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
    Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.